NDC 0173-0893

Trelegy Ellipta

Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate

Trelegy Ellipta is a Respiratory (inhalation) Powder in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Fluticasone Furoate; Umeclidinium Bromide; Vilanterol Trifenatate.

• Product ID: 0173-0893_0684a391-46b4-4c09-a6c4-c2a68cdae004
• NDC: 0173-0893
• Product Type: Human Prescription Drug
• Proprietary Name: Trelegy Ellipta
• Generic Name: Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate
• Dosage Form: Powder
• Route of Administration: RESPIRATORY (INHALATION)
• Marketing Start Date: 2020-09-09
• Marketing Category: NDA / NDA
• Application Number: NDA209482
• Labeler Name: GlaxoSmithKline LLC
• Substance Name: FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
• Active Ingredient Strength: 200 ug/1; ug/1; ug/1
• Pharm Classes: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0173-0893-10

1 TRAY in 1 CARTON (0173-0893-10) > 1 INHALER in 1 TRAY > 30 POWDER in 1 INHALER

• Marketing Start Date: 2020-09-09
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Trelegy Ellipta" or generic name "Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate"

NDC	Brand Name	Generic Name
0173-0887	Trelegy Ellipta	fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
0173-0893	Trelegy Ellipta	fluticasone furoate, umeclidinium bromide and vilanterol trifenatate